# Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial

> **NCT05899140** · PHASE4 · RECRUITING · sponsor: **Frieder Schaumburg** · enrollment: 100 (estimated)

## Conditions studied

- Skin Infection
- Staphylococcal Infections
- Staphylococcus Aureus Infection

## Interventions

- **DRUG:** Clindamycin
- **OTHER:** Standard of care

## Key facts

- **NCT ID:** NCT05899140
- **Lead sponsor:** Frieder Schaumburg
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-15
- **Primary completion:** 2026-03-29
- **Final completion:** 2026-07-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05899140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05899140, "Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05899140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*